These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 1730501)
1. Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants. Ivins BE; Welkos SL; Little SF; Crumrine MH; Nelson GO Infect Immun; 1992 Feb; 60(2):662-8. PubMed ID: 1730501 [TBL] [Abstract][Full Text] [Related]
2. Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen. Ivins BE; Welkos SL; Knudson GB; Little SF Infect Immun; 1990 Feb; 58(2):303-8. PubMed ID: 2105269 [TBL] [Abstract][Full Text] [Related]
3. Experimental anthrax vaccines: efficacy of adjuvants combined with protective antigen against an aerosol Bacillus anthracis spore challenge in guinea pigs. Ivins B; Fellows P; Pitt L; Estep J; Farchaus J; Friedlander A; Gibbs P Vaccine; 1995 Dec; 13(18):1779-84. PubMed ID: 8701593 [TBL] [Abstract][Full Text] [Related]
5. Study of immunization against anthrax with the purified recombinant protective antigen of Bacillus anthracis. Singh Y; Ivins BE; Leppla SH Infect Immun; 1998 Jul; 66(7):3447-8. PubMed ID: 9632621 [TBL] [Abstract][Full Text] [Related]
6. Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals. Iacono-Connors LC; Welkos SL; Ivins BE; Dalrymple JM Infect Immun; 1991 Jun; 59(6):1961-5. PubMed ID: 1903769 [TBL] [Abstract][Full Text] [Related]
7. Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores. Peachman KK; Li Q; Matyas GR; Shivachandra SB; Lovchik J; Lyons RC; Alving CR; Rao VB; Rao M Clin Vaccine Immunol; 2012 Jan; 19(1):11-6. PubMed ID: 22089245 [TBL] [Abstract][Full Text] [Related]
8. Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers. McBride BW; Mogg A; Telfer JL; Lever MS; Miller J; Turnbull PC; Baillie L Vaccine; 1998 May; 16(8):810-7. PubMed ID: 9627938 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of a standard human anthrax vaccine against Bacillus anthracis spore challenge in guinea-pigs. Ivins BE; Fellows PF; Nelson GO Vaccine; 1994 Aug; 12(10):872-4. PubMed ID: 7975827 [TBL] [Abstract][Full Text] [Related]
10. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model. Kumar M; Puranik N; Varshney A; Tripathi N; Pal V; Goel AK J Appl Microbiol; 2020 Aug; 129(2):443-452. PubMed ID: 32118336 [TBL] [Abstract][Full Text] [Related]
11. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits. Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139 [TBL] [Abstract][Full Text] [Related]
12. [The effect of the protective antigen of Bacillus anthracis on the formation of immunity under the action of live anthrax vaccines]. Abalakin VA; Buravtseva NP; Cherkasskiĭ BL Zh Mikrobiol Epidemiol Immunobiol; 1990 May; (5):72-5. PubMed ID: 2117320 [TBL] [Abstract][Full Text] [Related]
13. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits. Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302 [TBL] [Abstract][Full Text] [Related]
14. Anthrax spores make an essential contribution to vaccine efficacy. Brossier F; Levy M; Mock M Infect Immun; 2002 Feb; 70(2):661-4. PubMed ID: 11796596 [TBL] [Abstract][Full Text] [Related]
15. Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames. Vergis JM; Cote CK; Bozue J; Alem F; Ventura CL; Welkos SL; O'Brien AD Clin Vaccine Immunol; 2013 Jan; 20(1):56-65. PubMed ID: 23114705 [TBL] [Abstract][Full Text] [Related]
16. A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice. Wui SR; Kim HK; Han JE; Kim JM; Kim YH; Chun JH; Cho YJ; Lee NG Int Immunopharmacol; 2011 Sep; 11(9):1195-204. PubMed ID: 21492746 [TBL] [Abstract][Full Text] [Related]
18. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Welkos S; Little S; Friedlander A; Fritz D; Fellows P Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699 [TBL] [Abstract][Full Text] [Related]
19. Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax. Oscherwitz J; Feldman D; Yu F; Cease KB Vaccine; 2015 Jan; 33(3):430-6. PubMed ID: 25454087 [TBL] [Abstract][Full Text] [Related]
20. Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax. Peterson JW; Comer JE; Noffsinger DM; Wenglikowski A; Walberg KG; Chatuev BM; Chopra AK; Stanberry LR; Kang AS; Scholz WW; Sircar J Infect Immun; 2006 Feb; 74(2):1016-24. PubMed ID: 16428748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]